TRIM22 can activate the noncanonical NF-κB pathway by affecting IKKα

References

• Bouazzaoui A, Kreutz M, Eisert V, et al. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 2006;356:79–94
   PubMed Web of Science ®Google Scholar
• Gongora C, Tissot C, Cerdan C, Mechti N. The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. J Interferon Cytokine Res 2000;20:955–61
   PubMed Web of Science ®Google Scholar
• Di Pietro A, Kajaste-Rudnitski A, Oteiza A, et al. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J Virol 2013;87:4523–33
   PubMed Web of Science ®Google Scholar
• Gao B, Duan Z, Xu W, Xiong S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 2009;50:424–33
   PubMed Web of Science ®Google Scholar
• Gao B, Xu W, Zhong L, et al. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity. Eur J Immunol 2013;43:2174–84
   PubMed Web of Science ®Google Scholar
• Petersson J, Ageberg M, Sanden C, et al. The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G. Biol Cell 2012;104:462–75
   PubMed Web of Science ®Google Scholar
• Petersson J, Lonnbro P, Herr AM, et al. The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase. Exp Cell Res 2010;316:568–79
   PubMed Web of Science ®Google Scholar
• Duan Z, Gao B, Xu W, Xiong S. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem Biophys Res Commun 2008;374:502–6
   PubMed Web of Science ®Google Scholar
• Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. BioEssays 2005;27:1147–57
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan G, Sun Y, Rajmohan R, Lin VC. B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies. FEBS Lett 2009;583:2093–9
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan G, Sun Y, Tan SK, Lin VC. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies. Exp Cell Res 2009;315:1521–32
   PubMed Web of Science ®Google Scholar
• McNab FW, Rajsbaum R, Stoye JP, O'Garra A. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 2011;23:46–56
   PubMed Web of Science ®Google Scholar
• Yu S, Gao B, Duan Z, et al. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-kappaB activator. Biochem Biophys Res Commun 2011;410:247–51
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008;112:1794–803
   PubMed Web of Science ®Google Scholar
• Shi M, Deng W, Bi E, et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol 2008;9:369–77
   PubMed Web of Science ®Google Scholar
• Zha J, Han KJ, Xu LG, et al. The Ret finger protein inhibits signaling mediated by the noncanonical and canonical IkappaB kinase family members. J Immunol 2006;176:1072–80
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344–62
   PubMed Web of Science ®Google Scholar
• Sun SC. The noncanonical NF-kappaB pathway. Immunol Rev 2012;246:125–40
   PubMed Web of Science ®Google Scholar
• Gong J, Shen XH, Qiu H, et al. Rhesus monkey TRIM5alpha represses HIV-1 LTR promoter activity by negatively regulating TAK1/TAB1/TAB2/TAB3-complex-mediated NF-kappaB activation. Arch Virol 2011;156:1997–2006
   PubMed Web of Science ®Google Scholar
• Huang F, Xiao H, Sun BL, Yang RG. Characterization of TRIM62 as a RING finger E3 ubiquitin ligase and its subcellular localization. Biochem Biophys Res Commun 2013;432:208–13
   PubMed Web of Science ®Google Scholar
• Barr SD, Smiley JR, Bushman FD. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 2008;4:e1000007
   PubMed Web of Science ®Google Scholar
• Obad S, Brunnstrom H, Vallon-Christersson J, et al. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 2004;23:4050–9
   PubMed Web of Science ®Google Scholar
• Obad S, Olofsson T, Mechti N, et al. Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. Leuk Res 2007;31:995–1001
   PubMed Web of Science ®Google Scholar
• Zarnegar BJ, Wang Y, Mahoney DJ, et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008;9:1371–8
   PubMed Web of Science ®Google Scholar
• Liao G, Zhang M, Harhaj EW, Sun SC. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem 2004;279:26243–50
   PubMed Web of Science ®Google Scholar
• Xiao G, Cvijic ME, Fong A, et al. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J 2001;20:6805–15
   PubMed Web of Science ®Google Scholar
• Huang WC, Ju TK, Hung MC, Chen CC. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 2007;26:75–87
   PubMed Web of Science ®Google Scholar
• Hoberg JE, Popko AE, Ramsey CS, Mayo MW. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 2006;26:457–71
   PubMed Web of Science ®Google Scholar
• Yang CH, Murti A, Pfeffer LM. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival. J Biol Chem 2005;280:31530–6
   PubMed Web of Science ®Google Scholar